NEC orchestrating a brighter world
NEC Laboratories Europe
Contact Us Contact Us NEC Global NEC Global (English)

Press Releases (German)
 Transgene and NEC demonstrate high accuracy of AI-based neoantigen prediction for the design of individualized cancer vaccine TG4050

Transgene and NEC demonstrate high accuracy of AI-based neoantigen prediction for the design of individualized cancer vaccine TG4050

Back to Press Releases (German)
Top of this page